Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description Network Comparison Type Value Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2630 to 2679 of 6456 in total
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1315\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xpmc2 prevents mitotic catastrophe 2 homolog; xenopus prevents mitotic catastrophe 2 homolog. [source:refseq;acc:nm\_020385]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6123.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6597.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
473.96\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1316\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-actin capping protein alpha-2 subunit (capz alpha-2). [source:swissprot;acc:p47755]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6339.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6812.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
473.37\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr2e1 (nuclear receptor tlx) (tailless homolog) (tll) (htll). [source:swissprot;acc:q9y466]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6105.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6599.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08082\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1317\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor tr2. [source:swissprot;acc:p13056]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6105.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6599.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
p10-binding protein. [source:refseq;acc:nm\_024491]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5594.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6067.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
473.31\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1318\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apurinic/apyrimidinic endonuclease 2; apurinic/apyrimidinic endonuclease-like 2; apex nuclease-like 2. [source:refseq;acc:nm\_014481]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5546.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6019.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
473.07\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek1 (ec 2.7.1.37) (nima-related protein kinase 1) (ny-ren-55 antigen). [source:swissprot;acc:q96py6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5961.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6443.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08069\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1319\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 1 isoform c; epidermal growth factor receptor pathway substrate 8-related protein 1; eps8-related protein 1. [source:refseq;acc:nm\_139204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5685.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6157.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
472.32\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek3 (ec 2.7.1.37) (nima-related protein kinase 3) (hspk 36). [source:swissprot;acc:p51956]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5961.97\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6443.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08069\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1320\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glyceraldehyde 3-phosphate dehydrogenase, liver (ec 1.2.1.12) (gapdh). [source:swissprot;acc:p04406]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine hydroxymethyltransferase, mitochondrial precursor (ec 2.1.2.1) (serine methylase) (glycine hydroxymethyltransferase) (shmt). [source:swissprot;acc:p34897]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5449.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5921.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
472.29\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1321\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor kinase substrate eps8. [source:swissprot;acc:q12929]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5685.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6157.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
472.19\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of var1, 3-like 1. [source:refseq;acc:nm\_003171]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6439.79\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6959.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08066\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1322\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-1 (bcl-2 binding athanogene- 1) (bag-1) (glucocorticoid receptor-associated protein rap46). [source:swissprot;acc:q99933]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to trna synthetase class ii. [source:refseq;acc:nm\_152268]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5439.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5911.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
471.68\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1323\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 2; eps8-related protein 2; epidermal growth factor receptor pathway substrate 8-related protein 2. [source:refseq;acc:nm\_022772]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5685.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6156.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
471.4\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen synthase kinase-3 alpha (ec 2.7.1.37) (gsk-3 alpha). [source:swissprot;acc:p49840]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6439.79\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6959.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08066\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1324\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen synthase kinase-3 beta (ec 2.7.1.37) (gsk-3 beta). [source:swissprot;acc:p49841]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuroepithelial cell transforming gene 1; guanine nucleotide regulatory protein (oncogene); rho guanine nucleotide exchange factor (gef) 8. [source:refseq;acc:nm\_005863]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4086.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
4557.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
471.08\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1325\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 3; rhogef protein; 59.8 kda protein; exchange factor found in platelets and leukemic and neuronal tissues, xpln. [source:refseq;acc:nm\_019555]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2b catalytic subunit, alpha isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, alpha isoform) (cam-prp catalytic subunit). [source:swissprot;acc:q08209]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5656.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6112.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08047\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1326\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
down-regulated in metastasis. [source:refseq;acc:nm\_014503]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4086.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4557.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
471.08\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial gtp binding protein isoform v. [source:refseq;acc:nm\_032620]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6222.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6723.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08047\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1327\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-centractin (centractin) (centrosome-associated actin homolog) (actin-rpv) (arp1). [source:swissprot;acc:p42024]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5322.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5793.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
470.41\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
p protein (melanocyte-specific transporter protein). [source:swissprot;acc:q04671]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5656.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6111.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08045\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1328\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-centractin (actin-related protein 1b) (arp1b). [source:swissprot;acc:p42025]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5322.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5793.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
470.41\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2b catalytic subunit, beta isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, beta isoform) (cam-prp catalytic subunit). [source:swissprot;acc:p16299]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5656.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6111.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08044\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1329\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2b catalytic subunit, gamma isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, gamma isoform) (calcineurin, testis-specific catalytic subunit) (cam-prp catalytic subunit). [source:swissprot;acc:p48454]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5656.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6111.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08043\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
son of sevenless protein homolog 2 (sos-2). [source:swissprot;acc:q07890]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7497.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7967.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
469.13\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1330\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
isoleucyl-trna synthetase, cytoplasmic (ec 6.1.1.5) (isoleucine--trna ligase) (ilers) (irs). [source:swissprot;acc:p41252]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5779.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6244.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08041\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
upf0202 protein kiaa1709. [source:swissprot;acc:q9h0a0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3996.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4465.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
468.8\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1331\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol-3-phosphate dehydrogenase, mitochondrial precursor (ec 1.1.99.5) (gpd-m) (gpdh-m). [source:swissprot;acc:p43304]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6089.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6558.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
468.59\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transaldolase (ec 2.2.1.2). [source:swissprot;acc:p37837]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5799.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6265.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08034\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1332\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
my016 protein. [source:sptrembl;acc:q9h3k6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4775.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5158.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08033\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
n-acetyltransferase 5 (ec 2.3.1.-). [source:swissprot;acc:q9y6d2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5315.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5782.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
466.87\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1333\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
abl-interactor 2; abl-interacting protein 1 (sh3-containing protein); abl binding protein 3; arg protein tyrosine kinase-binding protein; abl-interactor protein 2b; similar to spectrin sh3 domain binding protein 1. [source:refseq;acc:nm\_005759]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5803.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6269.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0802\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 2 (alpha actinin skeletal muscle isoform 2) (f-actin cross linking protein). [source:swissprot;acc:p35609]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5887.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6354.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
466.76\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1334\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional aminoacyl-trna synthetase [includes: glutamyl-trna synthetase (ec 6.1.1.17) (glutamate--trna ligase); prolyl-trna synthetase (ec 6.1.1.15) (proline--trna ligase)]. [source:swissprot;acc:p07814]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5420.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5887.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
466.66\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin sh3 domain binding protein 1; eps8 binding protein; interactor protein ablbp4; abl-interactor protein 1 long; nap1 binding protein. [source:refseq;acc:nm\_005470]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5804.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6270.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08018\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1335\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer beta subunit (beta-coat protein) (beta-cop). [source:swissprot;acc:p53618]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10430.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9656.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1b (ec 2.7.1.-) (mirk protein kinase). [source:swissprot;acc:q9y463]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5887.86\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
6354.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
466.65\vspace{3pt}}\\\cline{1-2}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1336\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1a (ec 2.7.1.-) (protein kinase minibrain homolog) (mnbh) (hp86) (dual specificity yak1-related kinase). [source:swissprot;acc:q13627]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
6354.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
466.64\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
g1 to s phase transition protein 1 homolog (gtp-binding protein gst1-hs). [source:swissprot;acc:p15170]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6140.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6632.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1337\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation protein 4 homolog; pax6 neighbor gene; chromosome 11 open reading frame 19. [source:refseq;acc:nm\_019040]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5887.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6354.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
466.64\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gtp cyclohydrolase i (ec 3.5.4.16) (gtp-ch-i). [source:swissprot;acc:p30793]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4935.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5329.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0799\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1338\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 1 (alpha-actinin cytoskeletal isoform) (non-muscle alpha-actinin 1) (f-actin cross linking protein). [source:swissprot;acc:p12814]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5887.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6354.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
466.59\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5980.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6457.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07978\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1339\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphogluconate dehydrogenase, decarboxylating (ec 1.1.1.44). [source:swissprot;acc:p52209]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5988.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6464.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07964\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 4 (non-muscle alpha-actinin 4) (f-actin cross linking protein). [source:swissprot;acc:o43707]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5887.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6354.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
466.56\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 4 precursor (ec 3.4.25.1) (proteasome beta chain) (macropain beta chain) (multicatalytic endopeptidase complex beta chain) (proteasome chain 3) (hsn3) (hsbpros26). [source:swissprot;acc:p28070]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5979.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6453.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07935\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/